Document:

Exhibit 4.6

 

DESCRIPTION OF THE REGISTRANT’S
SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF
THE

SECURITIES EXCHANGE ACT OF 1934

 

The following description of the common
stock of Bionik Laboratories Corp. (referred to as “the Company”, “we”, “us” and “our”
unless specified otherwise) is based upon relevant provisions of the Company’s Amended and Restated Certificate of Incorporation,
as amended (the “Certificate of Incorporation”), the Company’s Amended and Restated Bylaws (the “Bylaws”)
and applicable provisions of law. We have summarized certain portions of the Certificate of Incorporation and Bylaws below. The
summary is not complete and is subject to, and is qualified in its entirety by express reference to, the provisions of our Certificate
of Incorporation and Bylaws, which are incorporated by reference to the Company’s Current Report on Form 8-K filed with the
Securities and Exchange Commission (the “SEC”) on March 4, 2015, as well as our Certificates of Amendment of the Certificate
of Incorporation, which are incorporated by reference to the Company’s Current Reports on Form 8-K filed with the SEC on
November 8, 2017, June 13, 2018, and October 29, 2018, respectively.

 

Authorized Capital Stock

 

Our
authorized capital stock consists of 500,000,000 shares of common stock, with a par value of $0.001 per share (“Common Stock”),
and 10,000,000 shares of preferred stock, with a par value of $0.001 per share.  

 

Description of Common Stock

 

Voting
Rights. Each holder of Common Stock will be entitled to one vote for each share of Common Stock held of record by such
holder with respect to all matters to be voted on or consented to by our stockholders, except as may otherwise be required by applicable
Delaware law. Except as otherwise required by law, the Certificate of Incorporation or the Bylaws, in all matters other than the
election of directors, the affirmative vote of a majority of the voting power of the shares present in person or represented by
proxy at the meeting and entitled to vote on the subject matter shall be the act of the stockholders, while directors shall be
elected by a plurality of the voting power of the shares present in person or represented by proxy at the meeting and entitled
to vote on the election of directors. Unless otherwise provided in the Certificate of Incorporation or Bylaws, any action required
or permitted to be taken by stockholders for or in connection with any corporate action may be taken without a meeting, without
prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the
holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such
action at a meeting at which all shares entitled to vote thereon were present and voted.

 

Dividends.
Holders of Common Stock are entitled to receive proportionately any dividends as may be declared by our board of directors,
out of funds that we may legally use to pay dividends, subject to any preferential dividend rights of any outstanding series of
preferred stock or series of preferred stock that we may designate and issue in the future.

 

     

     

    

 

Liquidation.
In the event of liquidation of the Company, the stockholders will be entitled to share in corporate assets on a pro rata
basis after the Company satisfies all liabilities and after provision is made for each class of capital stock having preference
over the Common Stock (if any).

 

Preemptive
and Redemption Rights. Holders of Common Stock have no preemptive, subscription, redemption or conversion rights. There
are no redemption or sinking fund provisions applicable to Common Stock.Exhibit 10.8

 

BIONIK LABORATORIES CORP.

 

July 30, 2015

 

Leslie Markow

 

Dear Leslie,

Bionik Laboratories is pleased to present you with an Offer
of Employment for the position of CFO reporting to the CEO, Peter Bloch, commencing August 4, 2015. This appointment is subject
to the approval of the Board on August 11, 2015.

 

It is understood that you will be giving TMF Group your resignation
during the week of August 4, 2015 and that your exit from your role as Managing Director Canada may take up to three months to
fully exit from but that your primary function is to be located and working with Bionik during this transition. You will make every
effort to exit from this role by August 31, 2015.

 

Your compensation package includes: an annual salary of $210,000.00(USD),
less statutory deductions, paid semi-monthly. You are eligible for up to 5% RRSP matching based on you contributing up to 5% and
a performance based bonus up to 30%. Your salary will be adjusted during the next 30-60 days while you make the transition from
part-time to full-time based on the time worked.

 

You will also receive the standard medical benefits package
made accessible to Bionik employees. Your current medical benefits will continue and will be adjusted to your new compensation.
You will additionally be entitled to four (4) weeks of paid vacation per twelve-month period of employment earned monthly. You
will also be eligible to stock options at the level of an executive of the Company.

 

In addition, your employment agreement will note a six (6) month
severance payment for any reason other than malfeasance or fraud committed by you.

 

Upon acceptance of this employment offer, you will be presented
with our Employment Agreement that is governed by the law of the Province of Ontario.

 

Your truly,

 

/s/ Peter Bioch

 

Peter Bioch

CEO Bionik Laboratories

 

 

	 	/s/ Leslie Markow August 4/15

 

 

 

 

 

	483 Bay Street, Office: N105 | Toronto ON M5G 2C9 | 416 640 7887 | info@bioniklabs.com	Bioniklabs.comExhibit 10.18

 

Amendment #1 to Employment Agreement
(September 1, 2017) between Eric Dusseux [“Dr. Dusseux”] and Bionik Laboratories Corp. and Bionik Laboratories Inc.
[“Bionik”]

 

This Amendment #1 is to record changes to the following sections
of the Employment Agreement:

 

Section 1.2 Reporting and Duties

 

Original: “The majority of time is to spent at Bionik’s
offices in Toronto currently located at...”

 

Amended: The
time will be split between Bionik's offices in Toronto and Watertown, and other locations in the US, Europe and globally, as reasonably
determined by Dr. Dusseux for the performance of his duties.

 

Section
2.5 Expense Reimbursement

 

Amended:
Expense reimbursement includes hotel and meal related expenses in Toronto and Boston area, and other locations globally as required
for business needs.

 

Section
2.8 Relocation to France

 

Original:
Upon termination or cessation of the employment of the Employee, except for cause, the Company will pay the reasonable expenses
incurred by the Employee in relocating from Toronto to France, including but not limited to the cost of breaking any rental lease,
subject to providing appropriate receipts.

 

Amended:
Upon termination or cessation of the employment of the Employee, except for cause, the Company will pay the reasonable expenses
incurred by the Employee in relocating back to France, subject to providing appropriate receipts.

 

Section
5.3 (b)

 

Amended:
Remove “a requirement that the Employee relocate more than 50 miles away from his principal work place under this Agreement
without his consent”.

 

Section
5.4 (d)

 

Amended:
Remove entire section. The Company will not provide continuation of Benefits (specifically health, dental, LTD or Life insurance)
through its provider in Canada in the event of Termination by the Company for other than cause.

 

Section
6.8 Notice

 

Amended
new address for Eric Dusseux: 

 

Bionik
Laboratories Inc.

 

Name:
Gerald Malone

 

Signature:
/s/ Gerald Malone

 

Date: November 12, 2019

 

     

     

    

 

	Bionik
    Laboratories Corp.	 	Eric
    Dusseux
	 	 	 
	Name:Gareld
    Malone	 	Signature:
    /s/ Eric Dusseux
	 	 	 
	Signature:
    /s/ Gerald Malone	 	Date: November 12,
    2019
	 	 	 
	Date: November 12, 2019EXHIBIT
4.5

 

MARATHON
PATENT GROUP, INC.

 

AMENDED
2018 EQUITY INCENTIVE PLAN

 

1.
Purpose of the Plan.

 

This
2018 Equity Incentive Plan (the “Plan”) is intended as an incentive, to retain in the employ of and as directors,
officers, consultants, advisors and employees to Marathon Patent Group, Inc., a Nevada corporation (the “Company”),
and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Internal Revenue Code of 1986, as
amended (the “Code”), persons of training, experience and ability, to attract new directors, officers, consultants,
advisors and employees whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active
interest of such persons in the development and financial success of the Company and its Subsidiaries.

 

It
is further intended that certain options granted pursuant to the Plan shall constitute incentive stock options within the meaning
of Section 422 of the Code (the “Incentive Options”) while certain other options granted pursuant to the Plan
shall be nonqualified stock options (the “Nonqualified Options”). Incentive Options and Nonqualified Options
are hereinafter referred to collectively as “Options.”

 

The
Company intends that the Plan meet the requirements of Rule 16b-3 (“Rule 16b-3”) promulgated under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and that transactions of the type specified in subparagraphs
(c) to (f) inclusive of Rule 16b-3 by officers and directors of the Company pursuant to the Plan will be exempt from the operation
of Section 16(b) of the Exchange Act. Further, the Plan is intended to satisfy the performance-based compensation exception to
the limitation on the Company’s tax deductions imposed by Section 162(m) of the Code with respect to those Options for which
qualification for such exception is intended. In all cases, the terms, provisions, conditions and limitations of the Plan shall
be construed and interpreted consistent with the Company’s intent as stated in this Section 1.

 

2.
Administration of the Plan.

 

The
Board of Directors of the Company (the “Board”) shall appoint and maintain as administrator of the Plan a Committee
(the “Committee”) consisting of two or more directors who are (i) “Independent Directors” (as such
term is defined under the rules of the NASDAQ Stock Market), (ii) “Non-Employee Directors” (as such term is defined
in Rule 16b-3) and (iii) “Outside Directors” (as such term is defined in Section 162(m) of the Code), which shall
serve at the pleasure of the Board. The Committee, subject to Sections 3, 5 and 6 hereof, shall have full power and authority
to designate recipients of Options, restricted stock (“Restricted Stock”), preferred stock which may or may
not be convertible (“Preferred Stock”), restricted share units (“RSUs”), and warrants which
may qualify as Incentive Warrants or Non-Qualified Warrants (as such terms are defined herein, collectively, “Warrants”),
and to determine the terms and conditions of the respective agreements (which need not be identical) and to interpret the provisions
and supervise the administration of the Plan. The Committee shall have the authority, without limitation, to designate which Options
granted under the Plan shall be Incentive Options and which shall be Nonqualified Options. To the extent any Option does not qualify
as an Incentive Option, it shall constitute a separate Nonqualified Option.

 

In
lieu of grants of Options and Restricted Stock, the Committee has the full power to and authority under the Plan to designate
Participants to receive shares of the Company’s Preferred Stock. Further, to the extent that the Committee shall determine
that the issuance of Options, Restricted Stock, RSUs or Warrants to a Participant (as defined below) could cause the beneficial
ownership by such Participant or its affiliates to exceed more than 9.99% of the total outstanding shares of Common Stock of the
Company upon the exercise of the Option or Warrant or the vesting of the Restricted Stock or RSU, as applicable, the Committee
shall also have the full power and authority under the Plan to designate Participants to receive shares of the Company’s
preferred stock in either a series of preferred that has already been authorized and designated by the Board or in a new series
of preferred that shall be authorized and designated by the Board in accordance with the Company’s Amended and Restated
Articles of Incorporation. The Committee shall determine the terms and conditions of the issuance of any Preferred Stock issued
pursuant to the Plan (which terms and conditions may include standard equity blockers, conditions to issuance and the conversion
price of the Preferred Stock) and any related agreements (which need not be identical) with respect to the issuance of the Preferred
Stock and to interpret the provisions and supervise the administration of the Plan with respect to the issuance of any Preferred
Stock.

 

    	A-1

    	 

    

 

Subject
to the provisions of the Plan, the Committee shall interpret the Plan and all Options, Restricted Stock, RSUs, Preferred Stock
and Warrants (collectively, the “Securities”) granted under the Plan, shall make such rules as it deems necessary
for the proper administration of the Plan, shall make all other determinations necessary or advisable for the administration of
the Plan and shall correct any defects or supply any omission or reconcile any inconsistency in the Plan or in any Securities
granted under the Plan in the manner and to the extent that the Committee deems desirable to carry into effect the Plan or any
Securities. The act or determination of a majority of the Committee shall be the act or determination of the Committee and any
decision reduced to writing and signed by all of the members of the Committee shall be fully effective as if it had been made
by a majority of the Committee at a meeting duly held for such purpose. Subject to the provisions of the Plan, any action taken
or determination made by the Committee pursuant to this and the other Sections of the Plan shall be conclusive on all parties.

 

In
the event that for any reason the Committee is unable to act or if the Committee at the time of any grant, award or other acquisition
under the Plan does not consist of two or more Non-Employee Directors, or if there shall be no such Committee, or if the Board
otherwise determines to administer the Plan, then the Plan shall be administered by the Board, and references herein to the Committee
(except in the proviso to this sentence) shall be deemed to be references to the Board, and any such grant, award or other acquisition
may be approved or ratified in any other manner contemplated by subparagraph (d) of Rule 16b-3; provided, however,
that grants to the Company’s Chief Executive Officer or to any of the Company’s other four most highly compensated
officers that are intended to qualify as performance-based compensation under Section 162(m) of the Code may only be granted by
the Committee.

 

3.
Designation of Optionees and Grantees.

 

The
persons eligible for participation in the Plan as recipients of Options (the “Optionees”), Restricted Stock,
Preferred Stock, RSUs or Warrants (the “Grantees” and together with Optionees, the “Participants”)
shall include directors, officers and employees of, and consultants and advisors to, the Company or any Subsidiary; provided that
Incentive Options may only be granted to employees of the Company and any Subsidiary. In selecting Participants, and in determining
the number of shares to be covered by each Option or Warrant or award of Restricted Stock, Preferred Stock or RSU granted to Participants,
the Committee may consider any factors it deems relevant, including, without limitation, the office or position held by the Participant
or the Participant’s relationship to the Company, the Participant’s degree of responsibility for and contribution
to the growth and success of the Company or any Subsidiary, the Participant’s length of service, promotions and potential.
A Participant who has been granted an Option, Restricted Stock, Preferred Stock, RSU or Warrant, hereunder, may be granted additional
Options, Restricted Stock, Preferred Stock, RSUs or Warrants, if the Committee shall so determine.

 

4.
Stock Reserved for the Plan.

 

Subject
to adjustment as provided in Section 8 hereof, a total of 2,745,639 shares of the Company’s common stock, par value
$0.0001 per share (the “Common Stock”), shall be subject to the Plan. The shares of Common Stock subject to
the Plan shall consist of unissued shares, treasury shares or previously issued shares held by any Subsidiary of the Company,
and such number of shares of Common Stock shall be and is hereby reserved for such purpose. Any of such shares of Common Stock
that may remain unissued and that are not subject to outstanding Options, Preferred Stock or Warrants at the termination of the
Plan shall cease to be reserved for the purposes of the Plan, but until termination of the Plan, the Company shall at all times
reserve a sufficient number of shares of Common Stock to meet the requirements of the Plan. Should any Securities expire or be
canceled prior to its exercise, satisfaction of conditions or vesting in full, as applicable, or should the number of shares of
Common Stock to be delivered upon the exercise or vesting in full of an Option or Warrant or award of Restricted Stock or RSU
or conversion of Preferred Stock be reduced for any reason, the shares of Common Stock theretofore subject to such Option, Warrant,
Restricted Stock, RSU or Preferred Stock, as applicable, may be subject to future Options, Warrants, Restricted Stock, RSUs or
Preferred Stock under the Plan, except where such reissuance is inconsistent with the provisions of Section 162(m) of the Code
where qualification as performance-based compensation under Section 162(m) of the Code is intended.

 

    	A-2

    	 

    

 

5A.
Terms and Conditions of Options.

 

Options
granted under the Plan shall be subject to the following conditions and shall contain such additional terms and conditions, not
inconsistent with the terms of the Plan, as the Committee shall deem desirable:

 

(a)
Option Price. The purchase price of each share of Common Stock purchasable under an Incentive Option shall be determined
by the Committee at the time of grant, but shall not be less than 100% of the Fair Market Value (as defined below) of such share
of Common Stock on the date the Option is granted; provided, however, that with respect to an Optionee who, at the
time such Incentive Option is granted, owns (within the meaning of Section 424(d) of the Code) more than 10% of the total combined
voting power of all classes of stock of the Company or of any Subsidiary, the purchase price per share of Common Stock shall be
at least 110% of the Fair Market Value per share of Common Stock on the date of grant. The purchase price of each share of Common
Stock purchasable under a Nonqualified Option shall not be less than 100% of the Fair Market Value of such share of Common Stock
on the date the Option is granted. The exercise price for each Option shall be subject to adjustment as provided in Section 8
below. “Fair Market Value” means the closing price on the final trading day immediately prior to the grant
date of the Common Stock on the NASDAQ Capital Market LLC or other principal securities exchange or OTC Bulletin Board on which
shares of Common Stock are listed (if the shares of Common Stock are so listed), or, if not so listed, the mean between the closing
bid and asked prices of publicly traded shares of Common Stock in the over the counter market, or, if such bid and asked prices
shall not be available, as reported by any nationally recognized quotation service selected by the Company, or as determined by
the Committee in a manner consistent with the provisions of the Code. Anything in this Section 5A(a) to the contrary notwithstanding,
in no event shall the purchase price of a share of Common Stock be less than the minimum price permitted under the rules and policies
of any national securities exchange on which the shares of Common Stock are listed.

 

(b)
Option Term. The term of each Option shall be fixed by the Committee, but no Option shall be exercisable more than ten
years after the date such Option is granted and in the case of an Incentive Option granted to an Optionee who, at the time such
Incentive Option is granted, owns (within the meaning of Section 424(d) of the Code) more than 10% of the total combined voting
power of all classes of stock of the Company or of any Subsidiary, no such Incentive Option shall be exercisable more than five
years after the date such Incentive Option is granted.

 

(c)
Exercisability. Subject to Section 5A(j) hereof, Options shall be exercisable at such time or times and subject to such
terms and conditions as shall be determined by the Committee at the time of grant; provided, however, that in the
absence of any Option vesting periods designated by the Committee at the time of grant, Options shall vest and become exercisable
as to one-third of the total number of shares subject to the Option on each of the first, second and third anniversaries of the
date of grant; and provided further that no Options shall be exercisable until such time as any vesting limitation required by
Section 16 of the Exchange Act, and related rules, shall be satisfied if such limitation shall be required for continued validity
of the exemption provided under Rule 16b-3(d)(3).

 

Upon
the occurrence of a “Change in Control” (as hereinafter defined), the Committee may accelerate the vesting and exercisability
of outstanding Options, in whole or in part, as determined by the Committee in its sole discretion. In its sole discretion, the
Committee may also determine that, upon the occurrence of a Change in Control, each outstanding Option shall terminate within
a specified number of days after notice to the Optionee thereunder, and each such Optionee shall receive, with respect to each
share of Common Stock subject to such Option, an amount equal to the excess of the Fair Market Value of such shares immediately
prior to such Change in Control over the exercise price per share of such Option; such amount shall be payable in cash, in one
or more kinds of property (including the property, if any, payable in the transaction) or a combination thereof, as the Committee
shall determine in its sole discretion.

 

    	A-3

    	 

    

 

For
purposes of the Plan, unless otherwise defined in an employment agreement between the Company and the relevant Optionee, a Change
in Control shall be deemed to have occurred if:

 

(i)
a tender offer (or series of related offers) shall be made and consummated for the ownership of 50% or more of the outstanding
voting securities of the Company, unless as a result of such tender offer more than 50% of the outstanding voting securities of
the surviving or resulting corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately
prior to the commencement of such offer), any employee benefit plan of the Company or its Subsidiaries, and their affiliates;

 

(ii)
the Company shall be merged or consolidated with another corporation, unless as a result of such merger or consolidation more
than 50% of the outstanding voting securities of the surviving or resulting corporation shall be owned in the aggregate by the
stockholders of the Company (as of the time immediately prior to such transaction), any employee benefit plan of the Company or
its Subsidiaries, and their affiliates;

 

(iii)
the Company shall sell substantially all of its assets to another corporation that is not wholly owned by the Company, unless
as a result of such sale more than 50% of such assets shall be owned in the aggregate by the stockholders of the Company (as of
the time immediately prior to such transaction), any employee benefit plan of the Company or its Subsidiaries and their affiliates;
or

 

(iv)
a Person (as defined below) shall acquire 50% or more of the outstanding voting securities of the Company (whether directly, indirectly,
beneficially or of record), unless as a result of such acquisition more than 50% of the outstanding voting securities of the surviving
or resulting corporation shall be owned in the aggregate by the stockholders of the Company (as of the time immediately prior
to the first acquisition of such securities by such Person), any employee benefit plan of the Company or its Subsidiaries, and
their affiliates.

 

Notwithstanding
the foregoing, if Change of Control is defined in an employment agreement between the Company and the relevant Optionee, then,
with respect to such Optionee, Change of Control shall have the meaning ascribed to it in such employment agreement.

 

For
purposes of this Section 5A(c), ownership of voting securities shall take into account and shall include ownership as determined
by applying the provisions of Rule 13d-3(d)(I)(i) (as in effect on the date hereof) under the Exchange Act. In addition, for such
purposes, “Person” shall have the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections
13(d) and 14(d) thereof; provided, however, that a Person shall not include (A) the Company or any of its Subsidiaries;
(B) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its Subsidiaries;
(C) an underwriter temporarily holding securities pursuant to an offering of such securities; or (D) a corporation owned, directly
or indirectly, by the stockholders of the Company in substantially the same proportion as their ownership of stock of the Company.

 

(d)
Method of Exercise. Options to the extent then exercisable may be exercised in whole or in part at any time during the
option period, by giving written notice to the Company specifying the number of shares of Common Stock to be purchased, accompanied
by payment in full of the purchase price, in cash, or by check or such other instrument as may be acceptable to the Committee.
As determined by the Committee, in its sole discretion, at or after grant, payment in full or in part may be made at the election
of the Optionee (i) in the form of Common Stock owned by the Optionee (based on the Fair Market Value of the Common Stock which
is not the subject of any pledge or security interest, (ii) in the form of shares of Common Stock or Preferred Stock withheld
by the Company from the shares of Common Stock otherwise to be received with such withheld shares of Common Stock having a Fair
Market Value equal to the exercise price of the Option, or (iii) by a combination of the foregoing, such Fair Market Value determined
by applying the principles set forth in Section 5A(a), provided that the combined value of all cash and cash equivalents and the
Fair Market Value of any shares surrendered to the Company is at least equal to such exercise price and except with respect to
(ii) above, such method of payment will not cause a disqualifying disposition of all or a portion of the Common Stock received
upon exercise of an Incentive Option. An Optionee shall have the right to dividends and other rights of a stockholder with respect
to shares of Common Stock purchased upon exercise of an Option at such time as the Optionee (i) has given written notice of exercise
and has paid in full for such shares, and (ii) has satisfied such conditions that may be imposed by the Company with respect to
the withholding of taxes.

 

    	A-4

    	 

    

 

(e)
Non-transferability of Options. Options are not transferable and may be exercised solely by the Optionee during his lifetime
or after his death by the person or persons entitled thereto under his will or the laws of descent and distribution. The Committee,
in its sole discretion, may permit a transfer of a Nonqualified Option to (i) a trust for the benefit of the Optionee, (ii) a
member of the Optionee’s immediate family (or a trust for his or her benefit) or (iii) pursuant to a domestic relations
order. Any attempt to transfer, assign, pledge or otherwise dispose of, or to subject to execution, attachment or similar process,
any Option contrary to the provisions hereof shall be void and ineffective and shall give no right to the purported transferee.

 

(f)
Termination by Death. Unless otherwise determined by the Committee, if any Optionee’s employment with or service
to the Company or any Subsidiary terminates by reason of death, the Option may thereafter be exercised, to the extent then exercisable
(or on such accelerated basis as the Committee shall determine at or after grant), by the legal representative of the estate or
by the legatee of the Optionee under the will of the Optionee, for a period of one (1) year after the date of such death (or,
if later, such time as the Option may be exercised pursuant to Section 14(d) hereof) or until the expiration of the stated term
of such Option as provided under the Plan, whichever period is shorter.

 

(g)
Termination by Reason of Disability. Unless otherwise determined by the Committee, if any Optionee’s employment with
or service to the Company or any Subsidiary terminates by reason of Disability (as defined below), then any Option held by such
Optionee may thereafter be exercised, to the extent it was exercisable at the time of termination due to Disability (or on such
accelerated basis as the Committee shall determine at or after grant), but may not be exercised after ninety (90) days after the
date of such termination of employment or service (or, if later, such time as the Option may be exercised pursuant to Section
14(d) hereof) or the expiration of the stated term of such Option, whichever period is shorter; provided, however,
that, if the Optionee dies within such ninety (90) day period, any unexercised Option held by such Optionee shall thereafter be
exercisable to the extent to which it was exercisable at the time of death for a period of one (1) year after the date of such
death (or, if later, such time as the Option may be exercised pursuant to Section 14(d) hereof) or for the stated term of such
Option, whichever period is shorter. “Disability” shall mean an Optionee’s total and permanent disability; provided,
that if Disability is defined in an employment agreement between the Company and the relevant Optionee, then, with respect to
such Optionee, Disability shall have the meaning ascribed to it in such employment agreement

 

(h)
Termination by Reason of Retirement. Unless otherwise determined by the Committee, if any Optionee’s employment with
or service to the Company or any Subsidiary terminates by reason of Normal or Early Retirement (as such terms are defined below),
any Option held by such Optionee may thereafter be exercised to the extent it was exercisable at the time of such Retirement (or
on such accelerated basis as the Committee shall determine at or after grant), but may not be exercised after ninety (90) days
after the date of such termination of employment or service (or, if later, such time as the Option may be exercised pursuant to
Section 14(d) hereof) or the expiration of the stated term of such Option, whichever date is earlier; provided, however,
that, if the Optionee dies within such ninety (90) day period, any unexercised Option held by such Optionee shall thereafter be
exercisable, to the extent to which it was exercisable at the time of death, for a period of one (1) year after the date of such
death (or, if later, such time as the Option may be exercised pursuant to Section 14(d) hereof) or for the stated term of such
Option, whichever period is shorter.

 

For
purposes of this paragraph (h), “Normal Retirement” shall mean retirement from active employment with the Company
or any Subsidiary on or after the normal retirement date specified in the applicable Company or Subsidiary pension plan or if
no such pension plan, age 65, and “Early Retirement” shall mean retirement from active employment with the
Company or any Subsidiary pursuant to the early retirement provisions of the applicable Company or Subsidiary pension plan or
if no such pension plan, age 55.

 

(i)
Other Terminations. Unless otherwise determined by the Committee upon grant, if any Optionee’s employment with or
service to the Company or any Subsidiary is terminated by such Optionee for any reason other than death, Disability, Normal or
Early Retirement or Good Reason (as defined below), the Option shall thereupon terminate, except that the portion of any Option
that was exercisable on the date of such termination of employment or service may be exercised for the lesser of ninety (90) days
after the date of termination (or, if later, such time as the Option may be exercised pursuant to Section 14(d) hereof) or the
balance of such Option’s term, which ever period is shorter. The transfer of an Optionee from the employ of or service to
the Company to the employ of or service to a Subsidiary, or vice versa, or from one Subsidiary to another, shall not be deemed
to constitute a termination of employment or service for purposes of the Plan.

 

    	A-5

    	 

    

 

(i)
In the event that the Optionee’s employment or service with the Company or any Subsidiary is terminated by the Company or
such Subsidiary for “cause” any unexercised portion of any Option shall immediately terminate in its entirety. For
purposes hereof, unless otherwise defined in an employment agreement between the Company and the relevant Optionee, “Cause”
shall exist upon a good-faith determination by the Board, following a hearing before the Board at which an Optionee was represented
by counsel and given an opportunity to be heard, that such Optionee has been accused of fraud, dishonesty or act detrimental to
the interests of the Company or any Subsidiary of Company or that such Optionee has been accused of or convicted of an act of
willful and material embezzlement or fraud against the Company or of a felony under any state or federal statute; provided,
however, that it is specifically understood that “Cause” shall not include any act of commission or omission
in the good-faith exercise of such Optionee’s business judgment as a director, officer or employee of the Company, as the
case may be, or upon the advice of counsel to the Company. Notwithstanding the foregoing, if Cause is defined in an employment
agreement between the Company and the relevant Optionee, then, with respect to such Optionee, Cause shall have the meaning ascribed
to it in such employment agreement.

 

(ii)
In the event that an Optionee is removed as a director, officer or employee by the Company at any time other than for “Cause”
or resigns as a director, officer or employee for “Good Reason” the Option granted to such Optionee may be exercised
by the Optionee, to the extent the Option was exercisable on the date such Optionee ceases to be a director, officer or employee.
Such Option may be exercised at any time within one (1) year after the date the Optionee ceases to be a director, officer or employee
(or, if later, such time as the Option may be exercised pursuant to Section 14(d) hereof), or the date on which the Option otherwise
expires by its terms; whichever period is shorter, at which time the Option shall terminate; provided, however,
if the Optionee dies before the Options terminate and are no longer exercisable, the terms and provisions of Section 5A(f) shall
control. For purposes of this Section 5A(i), and unless otherwise defined in an employment agreement between the Company and the
relevant Optionee, Good Reason shall exist upon the occurrence of the following:

 

	 	(A)	the
    assignment to Optionee of any duties inconsistent with the position in the Company that Optionee held immediately prior to
    the assignment;
	 	 	 
	 	(B)	a
    Change of Control resulting in a significant adverse alteration in the status or conditions of Optionee’s participation
    with the Company or other nature of Optionee’s responsibilities from those in effect prior to such Change of Control,
    including any significant alteration in Optionee’s responsibilities immediately prior to such Change in Control; and
	 	 	 
	 	(C)	the
    failure by the Company to continue to provide Optionee with benefits substantially similar to those enjoyed by Optionee prior
    to such failure.

 

Notwithstanding
the foregoing, if Good Reason is defined in an employment agreement between the Company and the relevant Optionee, then, with
respect to such Optionee, Good Reason shall have the meaning ascribed to it in such employment agreement.

 

(j)
Limit on Value of Incentive Option. The aggregate Fair Market Value, determined as of the date the Incentive Option is
granted, of Common Stock for which Incentive Options are exercisable for the first time by any Optionee during any calendar year
under the Plan (and/or any other stock option plans of the Company or any Subsidiary) shall not exceed $100,000.

 

5B.
Terms and Conditions of Warrants.

 

Warrants
may be issued under the Plan in the form of (a) warrants which qualify as Incentive Options (“Incentive Warrants”)
or (b) warrants that do not qualify as incentive stock options (“Non-Qualified Warrants”). Warrants issued
under the Plan shall be subject to the following conditions and shall contain such additional terms and conditions, not inconsistent
with the terms of the Plan, as the Committee shall deem desirable:

 

    	A-6

    	 

    

 

(a)
Warrant Grants. The Committee may grant Warrants to purchase shares of Common Stock from the Company, to such key persons,
and in such amounts and subject to such vesting and forfeiture provisions and other terms and conditions, as the Committee shall
determine, subject to the provisions of the Plan. The term “Incentive Warrant” means a Warrant that is intended to
qualify for special federal income tax treatment pursuant to Sections 421 and 422 of the Code as now constituted or subsequently
amended, or pursuant to a successor provision of the Code, and which is so designated in the applicable Award Agreement. Any Warrant
that is not specifically designated as an Incentive Warrant shall under no circumstances be considered an Incentive Warrant. Any
Warrant that is not an Incentive Warrant is referred to herein as a “Non-Qualified Warrant.” The Committee may grant
Incentive Warrants only to employees, and any grants of Warrants to any other key persons shall only be Non-Qualified Warrants.

 

(b)
Warrant Exercise Price. Each Award Agreement with respect to a Warrant shall set forth the amount (the “Warrant
Exercise Price”) payable by the Grantee to the Company upon exercise of the Warrant evidenced thereby. The Warrant Exercise
Price per share shall be determined by the Committee; provided, however, that with respect to an Grantee who, at
the time an Incentive Warrant is granted, owns (within the meaning of Section 424(d) of the Code) more than 10% of the total combined
voting power of all classes of stock of the Company or of any Subsidiary, the purchase price per share of Common Stock shall be
at least 110% of the Fair Market Value per share of Common Stock on the date of issuance. The purchase price of each share of
Common Stock purchasable under a Non-Qualified Warrant shall not be less than 100% of the Fair Market Value of such share of Common
Stock on the date such Warrant is issued. The exercise price for each Warrant shall be subject to adjustment as provided in Section
8 below.

 

(c)
Term. Subject to Section 5B(i) hereof, the term of each Warrant shall be fixed by the Committee, but no Warrant shall be
exercisable more than ten (10) years after the date such Warrant is issued.

 

(d)
Exercisability. Subject to Section 5B(i) hereof, Warrants shall be exercisable at such time or times and subject to such
terms and conditions as shall be determined by the Committee at the time of issuance; provided, however, that in
the absence of any Warrant vesting periods designated by the Committee at the time of issuance, Warrants shall vest and become
exercisable as to one-third of the total number of shares subject to the Warrant on each of the first, second and third anniversaries
of the date of issuance; and, provided further, that no Warrants shall be exercisable until such time as any vesting limitation
required by Section 16 of the Exchange Act, and related rules, shall be satisfied if such limitation shall be required for continued
validity of the exemption provided under Rule 16b-3(d)(3).

 

Upon
the occurrence of a “Change in Control” (as defined in Section 5A(c) hereof), the Committee may accelerate the vesting
and exercisability of outstanding Warrants, in whole or in part, as determined by the Committee in its sole discretion. In its
sole discretion, the Committee may also determine that, upon the occurrence of a Change in Control, each outstanding Warrant shall
terminate within a specified number of days after notice to the Grantee thereunder, and each such Grantee shall receive, with
respect to each share of Common Stock subject to such Warrant, an amount equal to the excess of the Fair Market Value of such
shares immediately prior to such Change in Control over the exercise price per share of such Warrant; such amount shall be payable
in cash, in one or more kinds of property (including the property, if any, payable in the transaction) or a combination thereof,
as the Committee shall determine in its sole discretion.

 

For
purposes of this Section 5B(d), ownership of voting securities shall take into account and shall include ownership as determined
by applying the provisions of Rule 13d-3(d)(I)(i) (as in effect on the date hereof) under the Exchange Act. In addition, for such
purposes, “Person” shall have the meaning given in Section 5A(c) hereof.

 

    	A-7

    	 

    

 

(e)
Method of Exercise. Warrants to the extent then exercisable may be exercised in whole or in part from time to time as to
all or part of the shares as to which such award is then exercisable, by giving written notice to the Company specifying the number
of shares of Common Stock to be purchased, accompanied by payment in full of the purchase price, in cash, or by check or such
other instrument as may be acceptable to the Committee. As determined by the Committee, in its sole discretion, at or after issuance,
payment in full or in part may be made at the election of the Grantee (i) in the form of Common Stock owned by the Grantee (based
on the Fair Market Value of the Common Stock which is not the subject of any pledge or security interest), (ii) in the form of
shares of Common Stock or Preferred Stock withheld by the Company from the shares of Common Stock otherwise to be received with
such withheld shares of Common Stock having a Fair Market Value equal to the Warrant Exercise Price of the Warrant, or (iii) by
a combination of the foregoing, such Fair Market Value determined by applying the principles set forth in Section 5B(b), provided
that the combined value of all cash and cash equivalents and the Fair Market Value of any shares surrendered to the Company is
at least equal to such exercise price and except with respect to (ii) above, such method of payment will not cause a disqualifying
disposition of all or a portion of the Common Stock received upon exercise of an Incentive Warrant. A Grantee shall have the right
to dividends and other rights of a stockholder with respect to shares of Common Stock purchased upon exercise of a Warrant at
such time as the Grantee (i) has given written notice of exercise and has paid in full for such shares, and (ii) has satisfied
such conditions that may be imposed by the Company with respect to the withholding of taxes.

 

(f)
Non-transferability of Warrants. Warrants are not transferable and may be exercised solely by the Grantee during his lifetime
or after his death by the person or persons entitled thereto under his will or the laws of descent and distribution. The Committee,
in its sole discretion, may permit a transfer of a Non-Qualified Warrant to (i) a trust for the benefit of the Grantee, (ii) a
member of the Grantee’s immediate family (or a trust for his or her benefit) or (iii) pursuant to a domestic relations order.
Any attempt to transfer, assign, pledge or otherwise dispose of, or to subject to execution, attachment or similar process, any
Warrant contrary to the provisions hereof shall be void and ineffective and shall give no right to the purported transferee.

 

(g)
Termination. Unless otherwise determined by the Committee at or after issuance, Warrants
issued to the Grantee that have not vested shall be forfeited upon termination of the Grantee in accordance with Section
5A(f), (g), (h) and (i), as applicable. The Committee may provide (on or after issuance) that restrictions or forfeiture conditions
relating to the Warrants will be waived in whole or in part in the event of termination resulting from specified causes, and the
Committee may in other cases waive in whole or in part restrictions or forfeiture conditions relating to the Warrants.

 

(h)
Special Rules for Incentive Warrants. No Warrant that remains exercisable for more than three months following a Grantee’s
termination of employment for any reason other than death (including death within three months after termination of employment
or within one year after a termination of employment due to disability) or disability, or for more than one year following a Grantee’s
termination of employment as the result of his becoming disabled, may be treated as an Incentive Warrant.

 

(i)
Limitations of Incentive Warrants.

 

(i)
Exercisability Limitation. The aggregate Fair Market Value, determined as of the date the Incentive Warrant is issued,
of Common Stock for which Incentive Warrants are exercisable for the first time by any Grantee during any calendar year under
the Plan (and/or any other stock option plans of the Company or any Subsidiary) shall not exceed $100,000.

 

(ii)
10% Owners. Notwithstanding the provisions of this Section 5B(d), an Incentive Warrant may not be issued under the Plan
to an individual who, at the time the Warrant is issued, owns stock possessing more than 10% of the total combined voting power
of all classes of stock of the Company or its Subsidiary (as such ownership may be determined for purposes of Section 422(b) (6)
of the Code), unless (i) at the time such Incentive Warrant is issued the Warrant Exercise Price is at least 110% of the Fair
Market Value of the shares subject thereto and (ii) the Incentive Warrant by its terms is not exercisable after the expiration
of five (5) years from the date it is issuance.

 

6A.
Terms and Conditions of Restricted Stock.

 

Restricted
Stock may be granted under this Plan aside from, or in association with, any other award and shall be subject to the following
conditions and shall contain such additional terms and conditions (including provisions relating to the acceleration of vesting
of Restricted Stock upon a Change of Control), not inconsistent with the terms of the Plan, as the Committee shall deem desirable:

 

    	A-8

    	 

    

 

(a)
Grantee rights. A Grantee shall have no rights to an award of Restricted Stock unless and until Grantee accepts the award
within the period prescribed by the Committee and, if the Committee shall deem desirable, makes payment to the Company in cash,
or by check or such other instrument as may be acceptable to the Committee. After acceptance and issuance of a certificate or
certificates, as provided for below, the Grantee shall have the rights of a stockholder with respect to Restricted Stock subject
to the non-transferability and forfeiture restrictions described in Section 6(d) below.

 

(b)
Issuance of Certificates. The Company shall issue in the Grantee’s name a certificate or certificates for the shares
of Common Stock associated with the award promptly after the Grantee accepts such award.

 

(c)
Delivery of Certificates. Unless otherwise provided, any certificate or certificates issued evidencing shares of Restricted
Stock shall not be delivered to the Grantee until such shares are free of any restrictions specified by the Committee at the time
of grant.

 

(d)
Forfeitability, Non-transferability of Restricted Stock. Shares of Restricted Stock are forfeitable until the terms of
the Restricted Stock grant have been satisfied. Shares of Restricted Stock are not transferable until the date on which the Committee
has specified such restrictions have lapsed. Unless otherwise provided by the Committee at or after grant, distributions in the
form of dividends or otherwise of additional shares or property in respect of shares of Restricted Stock shall be subject to the
same restrictions as such shares of Restricted Stock.

 

(e)
Change of Control. Upon the occurrence of a Change in Control as defined in Section 5A(c), the Committee may accelerate
the vesting of outstanding Restricted Stock, in whole or in part, as determined by the Committee, in its sole discretion.

 

(f)
Termination of Employment. Unless otherwise determined by the Committee at or after grant, in the event the Grantee ceases
to be an employee or otherwise associated with the Company for any other reason, all shares of Restricted Stock theretofore awarded
to him which are still subject to restrictions shall be forfeited and the Company shall have the right to complete the blank stock
power. The Committee may provide (on or after grant) that restrictions or forfeiture conditions relating to shares of Restricted
Stock will be waived in whole or in part in the event of termination resulting from specified causes, and the Committee may in
other cases waive in whole or in part restrictions or forfeiture conditions relating to Restricted Stock.

 

6B.
Terms and Conditions of Preferred Stock.

 

In
lieu of grants of Options, Warrants, Restricted Stock and RSUs, to the extent that the Committee shall determine that the issuance
of Options, Warrants, Restricted Stock or RSUs to a Participant could cause the beneficial ownership by such Participant or its
affiliates to exceed more than 9.99% of the total outstanding shares of Common Stock of the Company upon the exercise of the Option
or Warrant or the vesting of the Restricted Stock or RSU, as applicable, Preferred Stock may be granted under this Plan aside
from, or in association with, any other award and shall be subject to the following conditions and shall contain such additional
terms and conditions (including provisions relating to the acceleration of vesting of Restricted Stock or RSU upon a Change of
Control), not inconsistent with the terms of the Plan, as the Committee shall deem desirable:

 

(a)
Grantee rights. A Grantee shall have no rights to an award of Preferred Stock unless and until all of the following conditions
have been met (A) the Committee designates an award of Preferred Stock in a series of Preferred Stock that has already been authorized
and designated the Board, the Board passes a resolution authorizing and designating a new series of Preferred Stock on the terms
and conditions determined by the Committee, (B) if applicable, the Company files a Certificate of Designation with the Secretary
of State of the State of Nevada that sets forth the rights, preferences and other terms of any newly authorized and designated
series of the Preferred Stock, and (C) Grantee accepts the award within the period prescribed by the Committee and, if the Committee
shall deem desirable, executes an agreement that sets forth the terms and conditions of the issuance of the award of Preferred
Stock as may be acceptable to the Committee. After acceptance and issuance of a certificate or certificates, as provided for below,
the Grantee shall have the rights set forth in the applicable Certificate of Designation and any related agreement with respect
to the Preferred Stock award. The Preferred Stock shall also be subject to the non-transferability and forfeiture restrictions
described in Section 6B(d) below.

 

    	A-9

    	 

    

 

(b)
Issuance of Certificates. The Company shall issue in the Grantee’s name a certificate or certificates for the shares
of Preferred Stock associated with the award promptly after the Grantee accepts such award. The Company shall issue in the Grantee’s
name a certificate or certificates for the shares of Common Stock underlying the Preferred Stock associated with the award promptly
after the Grantee converts the Preferred Stock in accordance with the terms and conditions set forth in the applicable Certificate
of Designation and related agreement, if any.

 

(c)
Delivery of Certificates. Unless otherwise provided, any certificate or certificates issued evidencing shares of Preferred
Stock and/or the underlying Common Stock issuable upon the conversion of the Preferred Stock shall not be delivered to the Grantee
until such shares are free of any restrictions specified by the Committee at the time of grant.

 

(d)
Forfeitability, Non-transferability of Preferred Stock. Shares of Preferred Stock and any underlying shares of Common Stock
issuable upon the conversion of the Preferred Stock are forfeitable until the terms of the Preferred Stock grant have been satisfied.
Shares of Preferred Stock and any underlying shares of Common Stock issuable upon the conversion of the Preferred Stock are not
transferable until the date on which the Committee has specified such have lapsed. Unless otherwise provided by the Committee
at or after grant, distributions in the form of dividends or otherwise of additional shares or property in respect of shares of
Preferred Stock if the applicable Certificate of Designation provides for such distributions, shall be subject to the same restrictions
as such shares of Preferred Stock.

 

(e)
Change of Control. Upon the occurrence of a Change in Control as defined in Section 5A(c), the Committee may waive any
conditions and/or restrictions to the issuance of any contingent award of Preferred Stock, in whole or in part, as determined
by the Committee, in its sole discretion.

 

(f)
Termination of Employment or Consulting Agreement. Unless otherwise determined by the Committee at or after grant, in the
event the Grantee ceases to be, as applicable, an employee, a consultant or otherwise associated with the Company for any other
reason, all shares of Preferred Stock theretofore awarded to him which are still subject to restrictions shall be forfeited and
the Company shall have the right to complete the blank stock power. The Committee may provide (on or after grant) that restrictions
or forfeiture conditions relating to shares of Preferred Stock will be waived in whole or in part in the event of termination
resulting from specified causes, and the Committee may in other cases waive in whole or in part restrictions or forfeiture conditions
relating to Preferred Stock.

 

    	A-10

    	 

    

 

(g)
Maximum Percentage. Notwithstanding anything to the contrary set forth herein, the Company shall not effect any conversion
of Preferred Stock issued under the Plan, and no Participant shall have the right to convert any Preferred Stock, to the extent
that after giving effect to such conversion, the beneficial owner of such shares (together with such Participant’s affiliates)
would have acquired, through conversion of such Preferred Stock or otherwise, beneficial ownership of a number of shares of Common
Stock that exceeds 9.99% (the “Maximum Percentage”) of the number of shares of Common Stock outstanding immediately
after giving effect to such conversion. The Company shall not give effect to any voting rights of such Preferred Stock, and any
Participant shall not have the right to exercise voting rights with respect to any Preferred Stock pursuant hereto, to the extent
that giving effect to such voting rights would result in such Participant (together with its affiliates) being deemed to beneficially
own in excess of the Maximum Percentage of the number of shares of Common Stock outstanding immediately after giving effect to
such exercise, assuming such exercise as being equivalent to conversion. For purposes of the foregoing, the number of shares of
Common Stock beneficially owned by a Participant and its affiliates shall include the number of shares of Common Stock issuable
upon conversion of the Preferred Stock with respect to which the determination of such sentence is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (A) conversion of the remaining, nonconverted shares of Preferred
Stock beneficially owned by such Participant or any of its affiliates and (B) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company (including, without limitation, any notes or warrants) subject to a limitation
on conversion or exercise analogous to the limitation contained in this Section 6B(g) beneficially owned by such Participant or
any of its affiliates. Except as set forth in the preceding sentence, for purposes of this Section 6B(g), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act. For purposes of this Section 6B(g), in determining the
number of outstanding shares of Common Stock, a Participant may rely on the number of outstanding shares of Common Stock as reflected
in (1) the Company’s most recent Form 10-K, Form 10-Q, or Form 8-K, as the case may be, (2) a more recent public announcement
by the Company, or (3) any other notice by the Company or its transfer agent setting forth the number of shares of Common Stock
outstanding. For any reason at any time, upon the written request of any Participant, the Company shall within one (1) business
day following the receipt of such notice, confirm orally and in writing to any such Participant the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including the Preferred Stock, by such Holder and its affiliates since
the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the Participant
may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% specified in
such notice; provided, that (i) any such increase will not be effective until the sixty-first (61st) day after such notice is
delivered to the Company, and (ii) any such increase or decrease will apply only to the Holder providing such written notice and
not to any other Holder. In the event that the Company cannot pay any portion of any dividend, distribution, grant or issuance
hereunder to a Participant solely by reason of this Section 6B(g) (such shares, the “Limited Shares”), notwithstanding
anything to the contrary contained herein, the Company shall not be required to pay cash in lieu of the payment that otherwise
would have been made in such Limited Shares, but shall hold any such Limited Shares in abeyance for such Holder until such time,
if ever, that the delivery of such Limited Shares shall not cause the Participant to exceed the Maximum Percentage, at which time
such Participant shall be delivered such Limited Shares to the extent as if there had been no such limitation. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
6B(g) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership
limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.

 

6C.
Terms and Conditions of Restricted Stock Units.

 

Restricted
Stock Units, or RSUs, may be granted under this Plan aside from, or in association with, any other award and shall be subject
to the following conditions and shall contain such additional terms and conditions (including provisions relating to the acceleration
of vesting of RSUs upon a Change of Control), not inconsistent with the terms of the Plan, as the Committee shall deem desirable:

 

(a)
Grantee rights. A Grantee shall have no rights to an award of RSUs unless and until Grantee accepts the award within the
period prescribed by the Committee and, if the Committee shall deem desirable, makes payment to the Company in cash, or by check
or such other instrument as may be acceptable to the Committee. After acceptance and issuance of a certificate or certificates,
as provided for below, the Grantee shall have the rights of a stockholder with respect to the RSUs subject to the non-transferability
and forfeiture restrictions described in Section 6C(d) below.

 

(b)
Vesting. At the time of the grant of RSUs, the Committee may place restrictions on
RSUs that shall lapse, in whole or in part, upon the passage of time. Unless otherwise provided in an Award Agreement, upon the
vesting of a RSU, there shall be delivered to the Grantee, within 30 days of the date on which such Award (or any portion thereof)
vests, the number of shares of common stock equal to the number of RSUs becoming so vested.

 

(c)
Non-transferability of RSUs. Prior to the time that shares of common stock underlying
RSUs have been delivered to the Grantee, RSUs are not transferable and may be exercised solely by the Grantee during his
lifetime or after his death by the person or persons entitled thereto under his will or the laws of descent and distribution.
The Committee, in its sole discretion, may permit a transfer of an RSU to (i) a trust for the benefit of the Grantee, (ii) a member
of the Grantee’s immediate family (or a trust for his or her benefit) or (iii) pursuant to a domestic relations order. Any
attempt to transfer, assign, pledge or otherwise dispose of, or to subject to execution, attachment or similar process, any RSU
contrary to the provisions hereof shall be void and ineffective and shall give no right to the purported transferee.

 

    	A-11

    	 

    

 

(d)
Change of Control. Upon the occurrence of a Change in Control as defined in Section 5A(c), the Committee may accelerate
the vesting of outstanding RSUs, in whole or in part, as determined by the Committee, in its sole discretion.

 

(e)
Dividend Equivalents. To the extent provided in an Award Agreement, and subject to the requirements of Section 409A of
the Code, an award of RSUs may provide the Grantee with the right to receive dividend equivalent payments with respect to common
stock subject to such award, which payments may be settled in cash or common stock, as determined by the Committee. Any such settlements
and any crediting of dividend equivalents may, at the time of grant of the RSU, be made subject to the transfer restrictions,
forfeiture risks, vesting and conditions of the RSUs and subject to such other conditions, restrictions and contingencies as the
Committee shall establish at the time of grant of the RSU, including the reinvestment of such credited amounts in common stock
equivalents, provided that all such conditions, restrictions and contingencies shall comply with the requirements of Section 409A
of the Code.

 

(f)
Termination. Unless otherwise determined by the Committee at or after grant, RSUs
awarded to the Grantee that have not vested shall be forfeited upon termination of the Grantee in accordance with Section
5A(f), (g), (h) and (i), as applicable. The Committee may provide (on or after grant) that restrictions or forfeiture conditions
relating to the RSUs will be waived in whole or in part in the event of termination resulting from specified causes, and the Committee
may in other cases waive in whole or in part restrictions or forfeiture conditions relating to the RSUs.

 

7.
Term of Plan.

 

No
Securities shall be granted pursuant to the Plan on or after the date which is ten years from the effective date of the Plan,
but Options and Warrants and awards of Restricted Stock and/or Preferred Stock and/or RSUs theretofore granted may extend beyond
that date.

 

8.
Capital Change of the Company.

 

In
the event of any merger, reorganization, consolidation, recapitalization, stock dividend, or other change in corporate structure
affecting the Common Stock of the Company, the Committee shall make an appropriate and equitable adjustment in the number and
kind of shares reserved for issuance under the Plan and (A) in the number and price of shares subject to outstanding Options or
Warrants granted or issued under the Plan, to the end that after such event each Optionee’s or Grantee’s proportionate
interest shall be maintained (to the extent possible) as immediately before the occurrence of such event and (B) in the number
and conversion price of shares subject to outstanding Preferred Stock granted under the Plan, to the end that after such event
each Participant’s (who has received a grant of Preferred Stock) proportionate interest shall be maintained (to the extent
possible) as immediately before the occurrence of such event. The Committee shall, to the extent feasible, make such other adjustments
as may be required under the tax laws so that any Incentive Options or Incentive Warrants previously granted or issued shall not
be deemed modified within the meaning of Section 424(h) of the Code. Appropriate adjustments shall also be made in the case of
outstanding Restricted Stock or RSUs granted under the Plan.

 

The
adjustments described above will be made only to the extent consistent with continued qualification of the Option or Warrant under
Section 422 of the Code (in the case of an Incentive Option or Incentive Warrant) and Section 409A of the Code.

 

9.
Purchase for Investment/Conditions.

 

Unless
the Securities, and shares of Common Stock underlying such Securities, covered by the Plan have been registered under the Securities
Act of 1933, as amended (the “Securities Act”), or the Company has determined that such registration is unnecessary,
each person exercising or receiving Securities under the Plan may be required by the Company to give a representation in writing
that he is acquiring the securities for his own account for investment and not with a view to, or for sale in connection with,
the distribution of any part thereof. The Committee may impose any additional or further restrictions on awards of Securities
as shall be determined by the Committee at the time of award.

 

    	A-12

    	 

    

 

10.
Taxes.

 

(a)
The Company may make such provisions as it may deem appropriate, consistent with applicable law, in connection with any Securities
granted under the Plan with respect to the withholding of any taxes (including income or employment taxes) or any other tax matters.

 

(b)
If any Grantee, in connection with the acquisition of Restricted Stock, makes the election permitted under Section 83(b) of the
Code (that is, an election to include in gross income in the year of transfer the amounts specified in Section 83(b)), such Grantee
shall notify the Company of the election with the Internal Revenue Service pursuant to regulations issued under the authority
of Code Section 83(b).

 

(c)
If any Grantee shall make any disposition of shares of Common Stock issued pursuant to the exercise of an Incentive Option or
Incentive Warrant under the circumstances described in Section 421(b) of the Code (relating to certain disqualifying dispositions),
such Grantee shall notify the Company of such disposition within ten (10) days hereof.

 

11.
Effective Date of Plan.

 

The
Plan shall be effective on July 31, 2018; provided, however, that the Plan must subsequently be approved by majority vote of the
Company’s shareholders in accordance with the rules and regulations of the NASDAQ Stock Market LLC no later than July 31,
2019.

 

12.
Amendment and Termination.

 

The
Board may amend, suspend, or terminate the Plan, except that no amendment shall be made that would impair the rights of any Participant
under Securities theretofore granted without the Participant’s consent, and except that no amendment shall be made which,
without the approval of the shareholders of the Company would:

 

(a)
materially increase the number of shares that may be issued under the Plan, except as is provided in Section 8;

 

(b)
materially increase the benefits accruing to the Participants under the Plan;

 

(c)
materially modify the requirements as to eligibility for participation in the Plan;

 

(d)
decrease the exercise price of an Incentive Option or Incentive Warrant to less than 100% of the Fair Market Value per share of
Common Stock on the date of grant or issuance thereof or the exercise price of a Nonqualified Option or Non-Qualified Warrant
to less than 100% of the Fair Market Value per share of Common Stock on the date of grant or issuance thereof;

 

(e)
extend the term of any Option or Warrant beyond that provided for in Section 5A(b) and Section 5B(c), respectively;

 

(f)
except as otherwise provided in Sections 5A(d), 5B(e) and 8 hereof, reduce the exercise price of outstanding Options or Warrants
or effect repricing through cancellations and re-grants of new Options or Warrants;

 

(g)
increase the number of shares of Common Stock to be issued or issuable under the Plan to an amount that is equal to or in excess
of 19.99% of the number of shares of Common Stock outstanding before the issuance of the stock or securities; or

 

(h)
otherwise require stockholder approval pursuant to the rules and regulations of the NASDAQ Stock Market LLC.

 

    	A-13

    	 

    

 

Subject
to the forgoing, the Committee may amend the terms of any Option or Warrant theretofore granted, prospectively or retrospectively,
but no such amendment shall impair the rights of any Optionee or Grantee without the Optionee’s or Grantee’s consent.

 

It
is the intention of the Board that the Plan comply strictly with the provisions of Section 409A of the Code and Treasury Regulations
and other Internal Revenue Service guidance promulgated thereunder (the “Section 409A Rules”) and the Committee
shall exercise its discretion in granting awards hereunder (and the terms of such awards), accordingly. The Plan and any grant
of an award hereunder may be amended from time to time (without, in the case of an award, the consent of the Participant) as may
be necessary or appropriate to comply with the Section 409A Rules.

 

13.
Government Regulations.

 

The
Plan, and the grant and exercise or conversion, as applicable, of Securities hereunder, and the obligation of the Company to issue
and deliver shares under such Securities shall be subject to all applicable laws, rules and regulations, and to such approvals
by any governmental agencies, national securities exchanges and interdealer quotation systems as may be required.

 

14.
General Provisions.

 

(a)
Certificates. All certificates for shares of Common Stock or Preferred Stock delivered under the Plan shall be subject
to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations and other
requirements of the Securities and Exchange Commission, or other securities commission having jurisdiction, any applicable Federal
or state securities law, any stock exchange or interdealer quotation system upon which the Common Stock is then listed or traded
and the Committee may cause a legend or legends to be placed on any such certificates to make appropriate reference to such restrictions.

 

(b)
Employment Matters. Neither the adoption of the Plan nor any grant or award under the Plan shall confer upon any Participant
who is an employee of the Company or any Subsidiary any right to continued employment or, in the case of a Participant who is
a director, continued service as a director, with the Company or a Subsidiary, as the case may be, nor shall it interfere in any
way with the right of the Company or any Subsidiary to terminate the employment of any of its employees, the service of any of
its directors or the retention of any of its consultants or advisors at any time.

 

(c)
Limitation of Liability. No member of the Committee, or any officer or employee of the Company acting on behalf of the
Committee, shall be personally liable for any action, determination or interpretation taken or made in good faith with respect
to the Plan, and all members of the Committee and each and any officer or employee of the Company acting on their behalf shall,
to the extent permitted by law, be fully indemnified and protected by the Company in respect of any such action, determination
or interpretation.

 

(d)
Registration of Stock. Notwithstanding any other provision in the Plan, no Option or Warrant may be exercised unless and
until the Common Stock to be issued upon the exercise thereof has been registered under the Securities Act and applicable state
securities laws, or are, in the opinion of counsel to the Company, exempt from such registration in the United States. The Company
shall not be under any obligation to register under applicable federal or state securities laws any Common Stock to be issued
upon the exercise of an Option or Warrant granted or issued hereunder in order to permit the exercise of an Option or Warrant
and the issuance and sale of the Common Stock subject to such Option or Warrant, although the Company may in its sole discretion
register such Common Stock at such time as the Company shall determine. If the Company chooses to comply with such an exemption
from registration, the Common Stock issued under the Plan may, at the direction of the Committee, bear an appropriate restrictive
legend restricting the transfer or pledge of the Common Stock represented thereby, and the Committee may also give appropriate
stop transfer instructions with respect to such Common Stock to the Company’s transfer agent.

 

    	A-14

    	 

    

 

15.
Non-Uniform Determinations.

 

The
Committee’s determinations under the Plan, including, without limitation, (i) the determination of the Participants to receive
awards, (ii) the form, amount and timing of such awards, (iii) the terms and provisions of such awards and (ii) the agreements
evidencing the same, need not be uniform and may be made by it selectively among Participants who receive, or who are eligible
to receive, awards under the Plan, whether or not such Participants are similarly situated.

 

16.
Governing Law.

 

The
validity, construction, and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance
with the internal laws of the State of Nevada, without giving effect to principles of conflicts of laws, and applicable federal
law.

 

17.
Additional Issuance Restrictions.

 

If
the Company has not obtained the approval of its stockholders in accordance with NASDAQ Listing Rule 5635(d), then the Company
may not issue any Securities under this Plan that would upon the issuance of any Securities or upon the exercise on conversion
of such Securities, as applicable, into shares of the Company’s Common Stock, when aggregated with any other shares of Common
Stock (i) held by a Participant, (ii) underlying any convertible security held by a Participant, and (iii) issuable upon prior
exercise of any convertible security held by a Participant, would exceed 19.99% shares of the Company’s Common Stock, subject
to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the
Common Stock that occur after the date of the adoption of this Plan (such number of shares, the “Issuable Maximum”).
The Participant shall be entitled to a portion of the Issuable Maximum as reasonably determined by the Committee so as not to
violate NASDAQ Listing Rule 5635(d). In addition, the Participant may allocate its pro-rata portion of the Issuable Maximum among
Securities held by it in its sole discretion. Such portion shall be adjusted upward ratably in the event a Participant no longer
holds any Securities and the amount of shares issued to such Participant pursuant to its Securities was less than such Participant’s
pro-rata share of the Issuable Maximum.

 

    	A-15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]